We work every day to transform patients’ lives through science. See our community guidelines: https://t.co/Qd22DZ1dFwBristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.

Core values

- BMS is committed to advancing patient health globally, particularly in low- and middle-income countries, by ensuring access to medicines and investing in health equity grants[3][5].
- The company supports programs that improve health in the communities where they operate, and they are involved in strengthening healthcare worker knowledge and community-based supportive services[4].
- BMS focuses on discovering, developing, and delivering innovative medicines to help patients prevail over serious diseases, which directly improves health outcomes and quality of life[4][5].
- Their ESG strategy includes expanding the boundaries of science, which can lead to new treatments and better health outcomes[5].
- The company is committed to environmental sustainability, including initiatives like virtual power purchasing agreements for solar energy, which contributes to reducing carbon footprint and promoting sustainable practices[3][5].
- BMS emphasizes inclusion, diversity, and culture, ensuring a high-performing and inclusive global workforce, which promotes positive social change[5].
- BMS engages in various community programs, supports ethical work practices, and adheres to the U.N. principles on human rights, labor, environment, and anti-corruption[4].
- The company also invests in clinical trials in diverse areas, ensuring racially diverse clinical trial participants, which helps in addressing health disparities[3].